ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Endocrine-Related Cancer 8 (3) 161-173    DOI: 10.1677/erc.0.0080161
Copyright © 2001 by the Society for Endocrinology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (34)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zwick, E
Right arrow Articles by Ullrich, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zwick, E
Right arrow Articles by Ullrich, A
Endocrine Related Cancer, Vol 8, Issue 3, 161-173
Copyright © 2001 by Society for Endocrinology

Articles

Receptor tyrosine kinase signalling as a target for cancer intervention strategies

E Zwick, J Bange, and A Ullrich


In multicellular organisms, communication between individual cells is essential for the regulation and coordination of complex cellular processes such as growth, differentiation, migration and apoptosis. The plethora of signal transduction networks mediating these biological processes is regulated in part by polypeptide growth factors that can generate signals by activating cell surface receptors either in paracrine or autocrine manner. The primary mediators of such physiological cell responses are receptor tyrosine kinases (RTKs) that couple ligand binding to downstream signalling cascades and gene transcription. Investigations over the past 18 years have revealed that RTKs are not only key regulators of normal cellular processes but are also critically involved in the development and progression of human cancers. Therefore, signalling pathways controlled by tyrosine kinases offer unique opportunities for pharmaco logical intervention. The aim of this review is to give a broad overview of RTK signalling involved in tumorigenesis and the possibility of target-selective intervention for anti-cancer therapy.


This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
M Celano, S Schenone, D Cosco, M Navarra, E Puxeddu, L Racanicchi, C Brullo, E Varano, S Alcaro, E Ferretti, et al.
Cytotoxic effects of a novel pyrazolopyrimidine derivative entrapped in liposomes in anaplastic thyroid cancer cells in vitro and in xenograft tumors in vivo
Endocr. Relat. Cancer, June 1, 2008; 15(2): 499 - 510.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H. Sato, T. Yazawa, T. Suzuki, H. Shimoyamada, K. Okudela, M. Ikeda, K. Hamada, H. Yamada-Okabe, M. Yao, Y. Kubota, et al.
Growth Regulation via Insulin-Like Growth Factor Binding Protein-4 and -2 in Association with Mutant K-ras in Lung Epithelia
Am. J. Pathol., November 1, 2006; 169(5): 1550 - 1566.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Furukawa, M. Raffeld, C. Mateo, A. Sakamoto, T. W. Moody, T. Ito, D. J. Venzon, J. Serrano, and R. T. Jensen
Increased Expression of Insulin-Like Growth Factor I and/or Its Receptor in Gastrinomas Is Associated with Low Curability, Increased Growth, and Development of Metastases
Clin. Cancer Res., May 1, 2005; 11(9): 3233 - 3242.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Hiratsuka, K. Nakao, K. Nakamura, M. Katsuki, Y. Maru, and M. Shibuya
Membrane Fixation of Vascular Endothelial Growth Factor Receptor 1 Ligand-Binding Domain Is Important for Vasculogenesis and Angiogenesis in Mice
Mol. Cell. Biol., January 1, 2005; 25(1): 346 - 354.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Vicogne, K. Cailliau, D. Tulasne, E. Browaeys, Y. T. Yan, V. Fafeur, J. P. Vilain, D. Legrand, J. Trolet, and C. Dissous
Conservation of Epidermal Growth Factor Receptor Function in the Human Parasitic Helminth Schistosoma mansoni
J. Biol. Chem., September 3, 2004; 279(36): 37407 - 37414.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Lefevre, A.-L. Glotin, A. Calipel, F. Mouriaux, T. Tran, Z. Kherrouche, C.-A. Maurage, C. Auclair, and F. Mascarelli
Roles of Stem Cell Factor/c-Kit and Effects of Glivec(R)/STI571 in Human Uveal Melanoma Cell Tumorigenesis
J. Biol. Chem., July 23, 2004; 279(30): 31769 - 31779.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Blencke, A. Ullrich, and H. Daub
Mutation of Threonine 766 in the Epidermal Growth Factor Receptor Reveals a Hotspot for Resistance Formation against Selective Tyrosine Kinase Inhibitors
J. Biol. Chem., April 18, 2003; 278(17): 15435 - 15440.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. S. Jeruss, N. X. Liu, Y. Chung, G. Magrane, F. Waldman, S. Edgerton, X. Yang, and A. D. Thor
Characterization and chromosomal instability of novel derived cell lines from a wt-erbB-2 transgenic mouse model
Carcinogenesis, April 1, 2003; 24(4): 659 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. V. Lee, R. Schiff, X. Cui, D. Sachdev, D. Yee, A. P. Gilmore, C. H. Streuli, S. Oesterreich, and D. L. Hadsell
New Mechanisms of Signal Transduction Inhibitor Action: Receptor Tyrosine Kinase Down-Regulation and Blockade of Signal Transactivation
Clin. Cancer Res., January 1, 2003; 9(1): 516S - 523S.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Endocrinology.